Taro Pharmaceutical Industries Ltd
Change company Symbol lookup
Select an option...
TARO Taro Pharmaceutical Industries Ltd
META Meta Platforms Inc
HT Hersha Hospitality Trust
SABS SAB Biotherapeutics Inc
DIA SPDR® Dow Jones Industrial Average ETF Trust
SPY SPDR® S&P 500 ETF Trust
ABBNY Abb Ltd
FCF First Commonwealth Financial Corp
ARMN Aris Mining Corp
IBM International Business Machines Corp
Go

Health Care : Pharmaceuticals | Small Cap Value
Based in Israel

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical products in over 25 countries. The Company's owned product brands include Rokacet, with generic names, such as acetaminophen, codeine and caffeine; Topicort, with the generic name, desoximetasone; Etopan, with the generic name etodolac, and Ovide, with the generic name, malathion, among others. The Company's other generic products include acetazolamide, adapalene, alclometasone dipropionate, amiodarone hydrochloride, ammonium lactate, augmented betamethasone dipropionate, cetirizine hydrochloride, clobetasol propionate, clomipramine hydrochloride, clorazepate dipotassium, fluorouracil, ketoconazole, metronidazole, mupirocin and warfarin sodium, among others.

Price: Delayed
$37.17

Day's Change: -0.155 (-0.42%)

Bid: --

Ask: --

B/A Size: --

Day's High: 37.17

Day's Low: 36.79

Volume (Light) Today's volume of 9,274 shares is on pace to be much lighter than TARO's 10-day average volume of 19,362 shares.: 9,274

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.

The EDGAR data presented on this website is sourced from the U.S. Securities and Exchange Commission (SEC), as available on https://www.sec.gov/edgar.shtml.